Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines. (Q37844836)

24 August 2017

Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

sexually transmitted infection

12 May 2020

main subject

sexual transmission

0 references

0 references

author

Nicola Low

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

6

Nathalie Broutet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

author name string

Sami L Gottlieb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

Lori M Newman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

Gail Bolan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

Mary Kamb

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

language of work or name

English

0 references

publication date

25 February 2014

1 reference

24 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

page(s)

1527-1535

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

A review of clinical trials of human papillomavirus prophylactic vaccines

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Prevalence of HPV infection among men: A systematic review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Age-specific prevalence of human papillomavirus infection in males: a global review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

China's syphilis epidemic: a systematic review of seroprevalence studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Estimation of the impact of genital warts on health-related quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999--2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Human papillomavirus, human immunodeficiency virus and immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Neonatal mortality risk associated with preterm birth in East Africa, adjusted by weight for gestational age: individual participant level meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Prospective study of perinatal transmission of Chlamydia trachomatis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Assessing neonatal herpes reporting in the United States, 2000-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Risks of chronicity following acute hepatitis B virus infection: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

The epidemiology of human papillomavirus infection and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Risk of sequelae after Chlamydia trachomatis genital infection in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Comparison of assisted reproductive technology utilization and outcomes between Caucasian and African American patients in an equal-access-to-care setting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

A public health focus on infertility prevention, detection, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Worldwide patterns of infertility: is Africa different?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Relationships of stigma and shame to gonorrhea and HIV screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

A prospective study of the psychosocial impact of a positive Chlamydia trachomatis laboratory test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

The quality of life of patients with genital warts: a qualitative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Intimate partner violence and partner notification of sexually transmitted infections among adolescent and young adult family planning clinic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Global control of sexually transmitted infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Randomized controlled trials of individual-level, population-level, and multilevel interventions for preventing sexually transmitted infections: what has worked?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

HIV transmission rates in Thailand: evidence of HIV prevention and transmission decline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

How effective is syndromic management of STDs?: A review of current studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Cephalosporin-resistant gonorrhea in North America.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Trichomonas vaginalis genital infections: progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

High rates of reinfection and incidence of bacterial sexually transmitted infections in a cohort of female sex workers from two Indian cities: need for different STI control strategies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Uptake of regular chlamydia testing by U.S. women: a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Male circumcision for the prevention of HSV-2 and HPV infections and syphilis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Chlamydia control activities in Europe: cross-sectional survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

The arrested immunity hypothesis and the epidemiology of chlamydia control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Effective health interventions for adolescents that could be integrated with human papillomavirus vaccination programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.087

Current status and prospects for development of an HSV vaccine

7 January 2021

1 reference

12 December 2020

Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results

1 reference

12 December 2020

Strategy to accelerate progress towards the attainment of international development goals and targets related to reproductive health.

1 reference

12 December 2020

HIV/sexually transmitted infection epidemiology, management and control in the IUSTI Africa region: focus on sub-Saharan Africa

1 reference

12 December 2020

Vaccines against gonorrhea: current status and future challenges.

1 reference

12 December 2020

The theoretical impact and cost-effectiveness of vaccines that protect against sexually transmitted infections and disease

1 reference

12 December 2020

1 reference

12 December 2020

Utility and delivery of behavioural interventions to prevent sexually transmitted infections

1 reference

12 December 2020

Current status and prospects for development of a vaccine against Trichomonas vaginalis infections

1 reference

12 December 2020

Is Credé's prophylaxis for ophthalmia neonatorum still valid?

1 reference

12 December 2020

Sexually transmitted diseases treatment guidelines, 2010.

1 reference

12 December 2020

Current status of syphilis vaccine development: need, challenges, prospects

1 reference

12 December 2020

Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillance

1 reference

12 December 2020

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group

1 reference

12 December 2020

Applying new technologies for diagnosing sexually transmitted infections in resource-poor settings

1 reference

12 December 2020

Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years--United States, 2005-2008.

1 reference

12 December 2020

Prevention of herpes simplex virus type 2 transmission with antiviral therapy.

1 reference

12 December 2020

10.1016/J.VACCINE.2013.07.087

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6794147&resulttype=core&format=json